BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15097229)

  • 21. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension.
    Ravera M; Ratto E; Vettoretti S; Viazzi F; Leoncini G; Parodi D; Tomolillo C; Del Sette M; Maviglio N; Deferrari G; Pontremoli R
    J Nephrol; 2002; 15(5):519-24. PubMed ID: 12455718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased renal resistive index in patients with essential hypertension: a marker of target organ damage.
    Pontremoli R; Viazzi F; Martinoli C; Ravera M; Nicolella C; Berruti V; Leoncini G; Ruello N; Zagami P; Bezante GP; Derchi LE; Deferrari G
    Nephrol Dial Transplant; 1999 Feb; 14(2):360-5. PubMed ID: 10069189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk stratification in unselected primary care patients with newly detected arterial hypertension.
    Dieterle T; Sigle JP; Bengel G; Kiefer G; Brenneisen V; Martina B
    Hypertens Res; 2010 Jun; 33(6):607-15. PubMed ID: 20379186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertension.
    Pontremoli R; Viazzi F; Sofia A; Tomolillo C; Ruello N; Bezante GP; Del Sette M; Martinoli C; Lotti R; Sacchi G; Deferrari G
    Kidney Int Suppl; 1997 Dec; 63():S163-5. PubMed ID: 9407448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure.
    Cuspidi C; Valerio C; Sala C; Esposito A; Masaidi M; Negri F; Zanchetti A; Mancia G
    Blood Press Monit; 2008 Feb; 13(1):7-13. PubMed ID: 18199918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild renal dysfunction and cardiovascular risk in hypertensive patients.
    Leoncini G; Viazzi F; Parodi D; Ratto E; Vettoretti S; Vaccaro V; Ravera M; Deferrari G; Pontremoli R
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S88-90. PubMed ID: 14684681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target organ damage assessment in French hypertensive patients without established cardiovascular or renal disease: results of the PREVENT-A study.
    Rossignol P; Hosseini K; Tropeano AI; Fay R; Tsatsaris A; Guillemin F; Mounier-Vehier C
    J Hypertens; 2013 Jan; 31(1):177-85. PubMed ID: 23111625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension.
    Pontremoli R; Ravera M; Viazzi F; Nicolella C; Berruti V; Leoncini G; Giacopelli F; Bezante GP; Sacchi G; Ravazzolo R; Deferrari G
    Kidney Int; 2000 Feb; 57(2):561-9. PubMed ID: 10652033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diastolic dysfunction, left ventricular hypertrophy, and microalbuminuria in mild to moderate essential arterial hypertension].
    de Mora Martín M; Aranda Lara P; Aranda Lara FJ; Barakat S; Zafra Sánchez J; Rubio Alcaide A; Urda Valcárcel T; Alvarez Rubiera J; Vivancos Delgado R; Sánchez Calle JM; Malpartida F
    Rev Esp Cardiol; 1997 Apr; 50(4):233-8. PubMed ID: 9235605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal and cardiac abnormalities in primary hypertension.
    Leoncini G; Viazzi F; Conti N; Baratto E; Tomolillo C; Bezante GP; Deferrari G; Pontremoli R
    J Hypertens; 2009 May; 27(5):1064-73. PubMed ID: 19357534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome and multiple organ damage in essential hypertension.
    Cuspidi C; Valerio C; Giudici V; Negri F; Sala C; Zanchetti A; Mancia G
    Blood Press; 2008; 17(4):195-203. PubMed ID: 18821143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
    Wachtell K; Olsen MH; Dahlöf B; Devereux RB; Kjeldsen SE; Nieminen MS; Okin PM; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H
    J Hypertens; 2002 Mar; 20(3):405-12. PubMed ID: 11875307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microalbuminuria in primary hypertension: a guide to optimal patient management?
    Viazzi F; Cappadona F; Pontremoli R
    J Nephrol; 2016 Dec; 29(6):747-753. PubMed ID: 27417557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial clustering of hypertensive target organ damage in the community.
    Niiranen TJ; Lin H; Larson MG; Vasan RS
    J Hypertens; 2018 May; 36(5):1086-1093. PubMed ID: 29369144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulse pressure and subclinical cardiovascular damage in primary hypertension.
    Viazzi F; Leoncini G; Parodi D; Ravera M; Ratto E; Vettoretti S; Tomolillo C; Sette MD; Bezante GP; Deferrari G; Pontremoli R
    Nephrol Dial Transplant; 2002 Oct; 17(10):1779-85. PubMed ID: 12270984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
    Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
    J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal resistive index and cardiovascular organ damage in a large population of hypertensive patients.
    Tedesco MA; Natale F; Mocerino R; Tassinario G; Calabrò R
    J Hum Hypertens; 2007 Apr; 21(4):291-6. PubMed ID: 17252030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network).
    Mancusi C; Gerdts E; Losi MA; D'Amato A; Manzi MV; Canciello G; Trimarco V; De Luca N; de Simone G; Izzo R
    Int J Cardiol; 2017 Oct; 244():260-264. PubMed ID: 28629621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and target organ damage in untreated essential hypertensives.
    Cuspidi C; Meani S; Fusi V; Severgnini B; Valerio C; Catini E; Leonetti G; Magrini F; Zanchetti A
    J Hypertens; 2004 Oct; 22(10):1991-8. PubMed ID: 15361772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.